關於翔安｜翔安生醫

AcuSense BioMedical Technology Co., Ltd.

Founded in 2017, we are dedicated to developing innovative healthcare solutions using cutting-edge artificial intelligence (AI) and Internet of Things (IoT) technologies. Our core objective is to improve clinical efficiency, patient safety, and overall quality of care.

Founded in 2017, AcuSense BioMedical Technology Co., Ltd. is dedicated to developing innovative medical solutions using cutting-edge artificial intelligence (AI) and Internet of Things (IoT) technologies. Our core objective is to improve clinical efficiency, patient safety, and overall quality of healthcare.

2025.11

Became a Microsoft Cloud Services Reseller and AI Cloud Partner

2025.11

Achieved ISO 13485 Certification for Medical Device Quality Management Systems

2025.05

Selected to participate in the Startup Terrace Europe Program (Next DEstination), expanding into the Polish market and strengthening AcuSense's international brand presence

2025.01

Attended the Consumer Electronics Show (CES 2025) in the United States.

2024.10

Launch of Smart Ward POC Project in Three Ministry-affiliated Hospitals

2024.10

Gitex exhibits in Dubai, Middle East

2023.06

Signed a cooperation agreement with IKEM, a leading medical research center in the Czech Republic.

2023.03

Selected as a Czech accelerator Caelestinus Healthtech Incubator

2022.11

Attended MEDICA in Düsseldorf, Germany, and participated in a medical device industry visit in Prague, Czech Republic.

2022.09

Selected for the NSTC × MEDICA 2022 Program in Germany

2021.12

Top 10 in Qualcomm Taiwan Innovation Competition

2021.08

Received IRB approval for a clinical trial at Tainan Municipal An-Nan Hospital [IRB No.: TMANHIIO· C024]

2021.07

Shortlisted for the 9th Cloud Leopard Incubation Competition, collaborating with Lingqun Computer

2021.05

Two papers were selected as Best Conference Papers at the 3rd IEEE ECBIOS 2021.

2021.01

Selected for the TAcc+ Propel Accelerator Program by the Small and Medium Enterprise (SME) Administration

2020.06

Published clinical research findings from the European Association for the Study of Nephrology (ERA-EDTA 2020)

2020.04

Launched an overseas strategic alliance with Hugui Industrial and CymMetrik Group